Markets

Market Nav

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Medicamen Biotech Ltd.

Dec 24 BSE 382.10 ( -4.75 -1.23%)

Volume125

Prev. Close
386.85

Open Price
385.30

Today's Low / High

380.75 386.05

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

292.50 565.10

Dec 24 NSE 382.95( -4.80 -1.24%)

Volume16558

Prev. Close
387.75

Open Price
391.65

Today's Low / High

381.10 391.65

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

292.95 565.90

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	126.51	126.51	126.51	122.17	122.17

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	12.71	12.71	12.65	12.22	12.22
Total Share Capital	12.71	12.71	12.65	12.22	12.22

Reserves and Surplus	200.34	194.27	178.16	134.25	120.67
Total Reserves and Surplus	200.34	194.27	178.16	134.25	120.67
Total Shareholders Funds	213.05	206.98	190.81	146.47	132.89
Equity Share Application Money	0.00	0.00	2.61	0.00	0.00

NON-CURRENT LIABILITIES
Long Term Borrowings	3.73	1.26	0.87	5.07	6.40
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	0.00	0.28
Long Term Provisions	2.20	1.76	1.66	1.46	1.16
Total Non-Current Liabilities	5.94	3.01	2.53	6.53	7.84

CURRENT LIABILITIES
Short Term Borrowings	29.52	29.56	23.31	19.27	10.93
Trade Payables	42.65	38.95	47.59	43.30	32.21
Other Current Liabilities	4.79	15.12	10.98	9.29	4.90
Short Term Provisions	1.20	0.92	0.69	0.82	5.23
Total Current Liabilities	78.16	84.56	82.57	72.69	53.27

Total Capital And Liabilities	297.15	294.55	278.52	225.69	194.01

ASSETS
NON-CURRENT ASSETS
Tangible Assets	86.36	90.95	91.76	92.12	89.43
Intangible Assets	0.74	0.90	0.90	0.36	0.20
Fixed Assets	87.10	91.85	92.66	92.48	89.64
Deferred Tax Assets [Net]	2.83	2.51	1.88	0.50	0.00
Long Term Loans And Advances	1.24	1.22	1.11	0.87	0.78
Other Non-Current Assets	41.42	39.37	19.51	8.82	7.56
Total Non-Current Assets	132.60	134.96	115.15	102.66	97.97


CURRENT ASSETS
Inventories	62.14	59.38	45.06	27.01	5.20
Trade Receivables	68.90	55.26	65.26	63.22	52.55
Cash And Cash Equivalents	3.76	14.79	20.78	3.82	3.89
Short Term Loans And Advances	3.64	4.49	6.93	5.26	7.14
OtherCurrentAssets	26.11	25.68	25.34	23.72	27.25
Total Current Assets	164.55	159.59	163.36	123.04	96.03

Total Assets	297.15	294.55	278.52	225.69	194.01

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00
No. of Equity Shares (in Lacs)	126.51

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	12.71
Total Share Capital	12.71
Reserves and Surplus	200.34
Total Reserves and Surplus	200.34
Total Shareholders Funds	213.05
Equity Share Application Money	0.00
NON-CURRENT LIABILITIES
Long Term Borrowings	3.73
Deferred Tax Liabilities [Net]	0.00
Long Term Provisions	2.20
Total Non-Current Liabilities	5.94
CURRENT LIABILITIES
Short Term Borrowings	29.52
Trade Payables	42.65
Other Current Liabilities	4.79
Short Term Provisions	1.20
Total Current Liabilities	78.16
Total Capital And Liabilities	297.15
ASSETS
NON-CURRENT ASSETS
Tangible Assets	86.36
Intangible Assets	0.74
Fixed Assets	87.10
Deferred Tax Assets [Net]	2.83
Long Term Loans And Advances	1.24
Other Non-Current Assets	41.42
Total Non-Current Assets	132.60
CURRENT ASSETS
Inventories	62.14
Trade Receivables	68.90
Cash And Cash Equivalents	3.76
Short Term Loans And Advances	3.64
OtherCurrentAssets	26.11
Total Current Assets	164.55
Total Assets	297.15